BMEA
Price
$1.92
Change
+$0.09 (+4.92%)
Updated
Sep 5 closing price
Capitalization
114.26M
59 days until earnings call
CCCC
Price
$2.72
Change
+$0.05 (+1.87%)
Updated
Sep 5 closing price
Capitalization
193.58M
54 days until earnings call
Interact to see
Advertisement

BMEA vs CCCC

Header iconBMEA vs CCCC Comparison
Open Charts BMEA vs CCCCBanner chart's image
Biomea Fusion
Price$1.92
Change+$0.09 (+4.92%)
Volume$492.64K
Capitalization114.26M
C4 Therapeutics
Price$2.72
Change+$0.05 (+1.87%)
Volume$1.41M
Capitalization193.58M
BMEA vs CCCC Comparison Chart in %
Loading...
BMEA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BMEA vs. CCCC commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMEA is a Hold and CCCC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (BMEA: $1.92 vs. CCCC: $2.72)
Brand notoriety: BMEA and CCCC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BMEA: 63% vs. CCCC: 91%
Market capitalization -- BMEA: $114.26M vs. CCCC: $193.58M
BMEA [@Biotechnology] is valued at $114.26M. CCCC’s [@Biotechnology] market capitalization is $193.58M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMEA’s FA Score shows that 0 FA rating(s) are green whileCCCC’s FA Score has 1 green FA rating(s).

  • BMEA’s FA Score: 0 green, 5 red.
  • CCCC’s FA Score: 1 green, 4 red.
According to our system of comparison, CCCC is a better buy in the long-term than BMEA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMEA’s TA Score shows that 6 TA indicator(s) are bullish while CCCC’s TA Score has 3 bullish TA indicator(s).

  • BMEA’s TA Score: 6 bullish, 4 bearish.
  • CCCC’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, BMEA is a better buy in the short-term than CCCC.

Price Growth

BMEA (@Biotechnology) experienced а -1.54% price change this week, while CCCC (@Biotechnology) price change was +4.62% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

BMEA is expected to report earnings on Nov 04, 2025.

CCCC is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CCCC($194M) has a higher market cap than BMEA($114M). CCCC YTD gains are higher at: -24.444 vs. BMEA (-50.515). CCCC (-109.63M) and BMEA (-113.26M) have comparable annual earnings (EBITDA) . CCCC has more cash in the bank: 215M vs. BMEA (56.2M). BMEA has less debt than CCCC: BMEA (7.05M) vs CCCC (62.9M). CCCC has higher revenues than BMEA: CCCC (34.2M) vs BMEA (0).
BMEACCCCBMEA / CCCC
Capitalization114M194M59%
EBITDA-113.26M-109.63M103%
Gain YTD-50.515-24.444207%
P/E RatioN/AN/A-
Revenue034.2M-
Total Cash56.2M215M26%
Total Debt7.05M62.9M11%
TECHNICAL ANALYSIS
Technical Analysis
BMEACCCC
RSI
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
78%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
87%
Momentum
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
83%
MACD
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 5 days ago
82%
Bullish Trend 1 day ago
83%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 18 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
85%
Aroon
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
BMEA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TRUMF19.322.13
+12.42%
Terumo Corp.
PSMMY29.690.87
+3.02%
Persimmon Plc
BBXIB5.00N/A
N/A
BBX Capital, Inc.
ELTP0.70-0.01
-1.41%
Elite Pharmaceuticals, Inc.
NXNIF0.16N/A
-2.49%
NORTHX NICKEL CORP.

BMEA and

Correlation & Price change

A.I.dvisor indicates that over the last year, BMEA has been closely correlated with CSCI. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if BMEA jumps, then CSCI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMEA
1D Price
Change %
BMEA100%
+4.92%
CSCI - BMEA
66%
Closely correlated
N/A
CCCC - BMEA
40%
Loosely correlated
+1.87%
TCRX - BMEA
38%
Loosely correlated
+1.06%
CAI - BMEA
38%
Loosely correlated
-4.13%
ZLDAF - BMEA
37%
Loosely correlated
N/A
More

CCCC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CCCC has been loosely correlated with BEAM. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CCCC jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CCCC
1D Price
Change %
CCCC100%
+1.87%
BEAM - CCCC
46%
Loosely correlated
+12.62%
SYRE - CCCC
44%
Loosely correlated
+0.06%
OCUL - CCCC
44%
Loosely correlated
+7.09%
MGNX - CCCC
43%
Loosely correlated
+3.09%
KYMR - CCCC
43%
Loosely correlated
+3.10%
More